Predicting Chemotherapy Resistance in Gestational Trophoblastic Neoplasia: Ratio of Neutrophils, Lymphocytes, Monocytes, and Platelets

Gatot Nyarumenteng Adhipurnawan Winarno; Ayu Insafi Mulyantari; Andi Kurniadi; Dodi Suardi; Zulvayanti Zulvayanti; Nurvita Trianasari

doi:10.12659/MSM.938499

08 December 2022 : Clinical Research

Predicting Chemotherapy Resistance in Gestational Trophoblastic Neoplasia: Ratio of Neutrophils, Lymphocytes, Monocytes, and Platelets

Gatot Nyarumenteng Adhipurnawan Winarno^1ABCDEF*, Ayu Insafi Mulyantari^1ABCDEF, Andi Kurniadi^1BD, Dodi Suardi^1BD, Zulvayanti Zulvayanti^1BD, Nurvita Trianasari^2C

DOI: 10.12659/MSM.938499

Med Sci Monit 2022; 28:e938499

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 ROC curve analysis for combination of NLR, PLR, and FIGO score in high-risk GTN.

Back to the Article

Predicting Chemotherapy Resistance in Gestational Trophoblastic Neoplasia: Ratio of Neutrophils, Lymphocytes, Monocytes, and Platelets

Your Privacy